Current Assets
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)
Medtronic Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) decreased by 1.4% to $749M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.1%, from $852M to $749M. Over 5 years (FY 2020 to FY 2025), Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) shows an upward trend with a 47.0% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ1 2015
Last reportedQ4 2025Feb 24, 2026
Metric ID:
afs_debt_securities_unrealized_loss_less_than_12mHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $976M | $0 | $0 | $222M | $243M | $207M | $292M | $401M | $488M | $528M | $600M | $838M | $803M | $782M | $852M | $814M | $735M | $760M | $749M |
| QoQ Change | — | -100.0% | — | — | +9.5% | -14.8% | +41.1% | +37.3% | +21.7% | +8.2% | +13.6% | +39.7% | -4.2% | -2.6% | +9.0% | -4.5% | -9.7% | +3.4% | -1.4% |
| YoY Change | — | — | — | — | -75.1% | — | — | +80.6% | +100.8% | +155.1% | +105.5% | +109.0% | +64.5% | +48.1% | +42.0% | -2.9% | -8.5% | -2.8% | -12.1% |
Range$0 – $976M
CAGR-5.7%
Avg YoY Growth+46.5%
Median YoY Growth+48.1%
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) at Other Companies
Frequently Asked Questions
- What is Medtronic's available-for-sale debt securities - unrealized loss position (<12 months)?
- Medtronic (MDT) reported available-for-sale debt securities - unrealized loss position (<12 months) of $749M in Q4 2025.
- How has Medtronic's available-for-sale debt securities - unrealized loss position (<12 months) changed year-over-year?
- Medtronic's available-for-sale debt securities - unrealized loss position (<12 months) decreased by 12.1% year-over-year, from $852M to $749M.
- What is the long-term trend for Medtronic's available-for-sale debt securities - unrealized loss position (<12 months)?
- Over 5 years (2020 to 2025), Medtronic's available-for-sale debt securities - unrealized loss position (<12 months) has grown at a 47.0% compound annual growth rate (CAGR), from $109M to $749M.